ImageneBio Statistics
Total Valuation
ImageneBio has a market cap or net worth of $65.31 million. The enterprise value is -$54.11 million.
| Market Cap | 65.31M |
| Enterprise Value | -54.11M |
Important Dates
The next estimated earnings date is Saturday, August 15, 2026, before market open.
| Earnings Date | Aug 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ImageneBio has 11.28 million shares outstanding. The number of shares has decreased by -98.35% in one year.
| Current Share Class | 10.75M |
| Shares Outstanding | 11.28M |
| Shares Change (YoY) | -98.35% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 1.57% |
| Owned by Institutions (%) | 25.36% |
| Float | 5.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.49 |
| P/TBV Ratio | 0.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.39, with a Debt / Equity ratio of 0.02.
| Current Ratio | 18.39 |
| Quick Ratio | 17.67 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -86.15% and return on invested capital (ROIC) is -53.97%.
| Return on Equity (ROE) | -86.15% |
| Return on Assets (ROA) | -45.61% |
| Return on Invested Capital (ROIC) | -53.97% |
| Return on Capital Employed (ROCE) | -41.93% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.17M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -340,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 5.75 |
| 200-Day Moving Average | 6.48 |
| Relative Strength Index (RSI) | 49.33 |
| Average Volume (20 Days) | 10,536 |
Short Selling Information
The latest short interest is 404,370, so 3.59% of the outstanding shares have been sold short.
| Short Interest | 404,370 |
| Short Previous Month | 395,934 |
| Short % of Shares Out | 3.59% |
| Short % of Float | 6.97% |
| Short Ratio (days to cover) | 27.06 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -54.54M |
| Pretax Income | -50.23M |
| Net Income | -53.89M |
| EBITDA | -54.04M |
| EBIT | -54.54M |
| Earnings Per Share (EPS) | -$7.06 |
Balance Sheet
The company has $117.21 million in cash and $2.42 million in debt, with a net cash position of $114.79 million or $10.18 per share.
| Cash & Cash Equivalents | 117.21M |
| Total Debt | 2.42M |
| Net Cash | 114.79M |
| Net Cash Per Share | $10.18 |
| Equity (Book Value) | 123.33M |
| Book Value Per Share | 10.93 |
| Working Capital | 115.37M |
Cash Flow
| Operating Cash Flow | -55.41M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 496,750 |
| Net Borrowing | 15.00M |
| Free Cash Flow | -55.41M |
| FCF Per Share | -$4.91 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ImageneBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 98.35% |
| Shareholder Yield | 98.35% |
| Earnings Yield | -88.80% |
| FCF Yield | -91.32% |
Analyst Forecast
The average price target for ImageneBio is $13.00, which is 124.53% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.00 |
| Price Target Difference | 124.53% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ImageneBio has an Altman Z-Score of 1.43 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.43 |
| Piotroski F-Score | 1 |